Cit Co., Ltd.
FDA inspection history in Dangjin, South Korea, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at Dangjin, South Korea.
Cited most
Across all Cit Co. observations on file
- 21 CFR 2101
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.166Stability testing1
- 21 CFR 211.194Laboratory records1
- 21 CFR 211.68Automatic, mechanical, and electronic equipment1
The complete Cit Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Dangjin, South Korea
One Form 483 · 2023 · 5 observations
Latest: Form 483, Dec 8, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-12-08 | 483 Form 483 | Dangjin, South Korea | 5 | $99 |
Investigators on these documents
FEI number 3008160676 · most recent document Dec 8, 2023
About Cit Co., Ltd.
How many FDA Form 483s has Cit Co., Ltd. received?
FDA Intel has 1 Form 483 on file for Cit Co., Ltd.; the most recent is dated Dec 8, 2023.
When was Cit Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Cit Co., Ltd. is a Form 483 dated Dec 8, 2023, for the site in Dangjin, South Korea.
What did FDA cite at Cit Co., Ltd.?
The regulations cited most in the observations on file for Cit Co., Ltd. are 21 CFR 210, 1 time; 21 CFR 211.165 (Testing and release for distribution), 1 time; 21 CFR 211.166 (Stability testing), 1 time.